ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A new immune-related gene signature predicts the prognosis and immune escape of bladder cancer

Liu, Yang; Han, Yan-Song; Wang, Jin-Feng; Pang, Zhong-Qi; Wang, Jian-She; Zhang, Lu; He, Jia-Xin; Shen, Lin-Kun; Ji, Bo; Ding, Bei-Chen*; Ren, Ming-Hua*哈尔滨医科大学; 1
Cancer Biomarkers2023DOI: 10.3233/CBM-230190
19阅读
引用收藏
分享

摘要

BACKGROUND: The biological roles of immune-related genes (IRGs) in bladder cancer (BC) need to be further elucidated. @@@ OBJECTIVE: To elucidate the predictive value of IRGs for prognosis and immune escape in BC. @@@ METHODS: We comprehensively analyzed the transcriptomic and clinical information of 430 cases, including 19 normal and 411 BC patients from the TCGA database, and verified 165 BC cases in the GSE13507 dataset. The risk model was constructed based on IRGs by applying LASSO Cox regression and exploring the relationship between the risk score and prognosis, gene mutations, and immune escape in BC patients. @@@ RESULTS: We identified 4 survival-related genes (PSMC1, RAC3, ROBO2 and ITGB3) among 6,196 IRGs in both the TCGA and GES13507 datasets" which were used to establish a gene risk model by applying LASSO Cox regression. The results showed that the high-risk (HR) group was closely associated with poor survival or advanced pathological stage of BC. Furthermore, the risk score was found to be an independent risk factor for prognosis of BC patients. In addition, high-risk individuals showed a greater prevalence of TP53 mutations lower CD8+ T-cell and NK cell infiltration, higher Treg cell infiltration, higher expression of PD-L1, and higher immune exclusion scores than those in the low-risk (LR) group. Finally, the experimental verification shows that the model construction gene, especially PMSC1, plays an important role in the growth and metastasis of bladder cancer. @@@ CONCLUSIONS: These evidences revealed the vital role of IRGs in predicting prognosis, TP53 mutation and immune escape in BC patients.

学科与关键词

关键词
Bladder cancerprognosisimmune escaperisk model
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Cancer Biomarkers
发表日期
2023
卷期
第 38 卷, 第 4 期
页码
567-581
DOI
10.3233/CBM-230190
语言
ENGLISH
成果收录
SCIE
资助标注
Horizontal Project of Heilongjiang Renxin Medical Assistance Foundation; Natural Science Foundation of Heilongjiang Province [LH2019H030]; National Natural Science Foundation of China [82002680]; Heilongjiang Charity Fund General Association

作者

  • L

    Liu, Yang (第一作者)

    1 · harbin med univ

  • H

    Han, Yan-Song

    1 · harbin med univ

查看全部 11 位作者收起作者
  • W

    Wang, Jin-Feng

    1 · harbin med univ

  • P

    Pang, Zhong-Qi

    1 · harbin med univ

  • W

    Wang, Jian-She

    1 · harbin med univ

  • Z

    Zhang, Lu

    1 · harbin med univ

  • H

    He, Jia-Xin

    1 · harbin med univ

  • S

    Shen, Lin-Kun

    1 · harbin med univ

  • J

    Ji, Bo

    1 · harbin med univ

  • D

    Ding, Bei-Chen (通讯)

    1 · harbin med univ

  • R

    Ren, Ming-Hua (通讯)

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417